We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine Test Produces Antibiotic Susceptibility Results Directly

By LabMedica International staff writers
Posted on 10 Jul 2019
Antibiotic susceptibility testing, or AST, is a widely used method of evaluating antibiotic resistance and determining patient treatment plans in clinical settings. More...
There are a number of different methods of AST such as agar dilution, broth dilution and disc diffusion assays.

Empiric treatment is often started before laboratory microbiological reports are available when treatment should not be delayed due to the seriousness of the disease. The effectiveness of individual antibiotics varies with the location of the infection, the ability of the antibiotic to reach the site of infection, and the ability of the bacteria to resist or inactivate the antibiotic.

Microbiologists at the Groupe Hospitalier Paris-Saint-Joseph (Paris, France) collected urine samples were collected from 107 patients aged 52 to 80 years with urinary tract infections (UTIs) (ratio of females to males 2:1). The median C-reactive protein was 104 mg/L (range, 39-145). The urine specimens displayed a median leukocyturia of 380/mm3 (range, 192-1,497) and median bacteriuria of 106 colony forming units/mL (range, 105-107). Only gram-negative bacilli were evident on direct examination using microscopy.

A novel rapid method was performed by direct inoculation of urine on Mueller-Hinton Rapid-SIR (MHR-SIR) agar using a swab according to a standard protocol. The resulting inhibition zones were read from digital images after eight-hours of incubation and were interpreted using standard methods. Of 70 patients who were currently receiving antibiotic therapy, the results prompted a shift in therapy for 29 patients, with no modification for the remaining 41. The most commonly used antibiotics were third generation cephalosporins, followed by fluoroquinolones, beta-lactamase inhibitors, fosfomycin, and nitrofurantoin. The rapid results lead to treatment escalation in 7% of the patients and de-escalation in 30%. The average time to obtain results was 7.2 ± 1.6 hours, representing a time saving of 42.6 hours compared with the standard technique.

The team noted that the method was affordable, with an average cost of USD 6 per sample for 16 antibiotics chosen by a microbiologist. Benoît Pilmis, MD, an infectious disease specialist and a co-author of the study, said, “The diagnosis of urinary tract infection generally requires a 48-hour microbiological delay to obtain the antibiotic susceptibility test. In the context of multidrug resistance, reducing the time to obtain antibiotic susceptibility test results is an essential issue to avoid treatment failure. The rapidity of the results impact the therapeutic management of patients as it enables not only the prescription of the most relevant antibiotic, but also the reduction of the spectrum of antibiotic therapy.” The study was presented at Annual meeting of the American Society of Microbiology, held June 7-11, 2019, in Atlanta, GA, USA.

Related Links:
Groupe Hospitalier Paris-Saint-Joseph


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.